GSTM1-null and GSTA1-low Activity Genotypes Are Associated with Enhanced Oxidative Damage in Bladder Cancer

Overview

Journal Redox Rep

Specialties Biochemistry
Biology
Endocrinology

Date 2013 Feb 12

PMID 23394311

Citations 11

Authors

Ana Savic-Radojevic

Tatjana Djukic

Tatjana Simic

Marija Pljesa-Ercegovac

Dejan Dragicevic

Tatjana Pekmezovic

Milica Cekerevac

Veljko Santric

Marija Matic

Affiliations

Soon will be listed here.

Abstract

Objectives: To examine the association between gene variants of the detoxifying and antioxidant enzymes glutathione transferase M1 (GSTM1) and glutathione transferase A1 (GSTA1) and the extent of oxidative damage in patients with transitional cell carcinoma (TCC) of the urinary bladder.

Methods: GSTM1 deletion polymorphism was identified by polymerase chain reaction, and the restriction fragment length polymorphism method was used for the single nucleotide polymorphism of GSTA1. Enzyme immunoassay was used to determine markers of DNA (8-hydroxy-2′-deoxyguanosine, 8-OHdG) and lipid (8-epiprostaglandin F2α) oxidative damage in the urine of 80 TCC patients and 60 age-matched controls.

Results: Urinary 8-OHdG and 8-epi-prostaglandin F2α concentrations in TCC patients were significantly higher than in controls (P=0.043 and 0.001, respectively). GSTM1 and GSTA1 polymorphisms influence vulnerability to both DNA and lipid oxidation, with the GSTM1-null gene variant having a more pronounced effect. A significant effect of combined GSTM1 and GSTA1 genotypes on the extent of oxidative damage was found only for 8-OHdG (P=0.018). In addition, TCC patients with the most malignant tumors exhibited significantly higher frequencies of GSTM1-null or GSTA1-low activity genotypes, associated with a twofold increase in urinary 8-OHdG concentration (P=0.044).

Conclusions: Our results suggest that absent GSTM1 or reduced GSTA1 antioxidant activity may increase the accumulation of oxidative DNA damage, thereby contributing to the malignant potential of TCC.

Citing Articles

Nrf-2/HO-1 activation protects against oxidative stress and inflammation induced by metal welding fume UFPs in 16HBE cells.

Ying M, Yang Y, Huo Q, Sun J, Hong X, Yang F Sci Rep. 2024; 14(1):24057.

PMID: 39402078 PMC: 11473639. DOI: 10.1038/s41598-024-74599-8.

The role of SOD2 and NOS2 genes in the molecular aspect of bladder cancer pathophysiology.

Grebowski R, Saluk J, Bijak M, Szemraj J, Wigner-Jeziorska P Sci Rep. 2023; 13(1):14491.

PMID: 37660159 PMC: 10475080. DOI: 10.1038/s41598-023-41752-8.

A novel pyroptosis-related model for prognostic prediction in esophageal squamous cell carcinoma: a bioinformatics analysis.

Shi Q, Liu M, Wang S, Ding P, Wang Y J Thorac Dis. 2023; 15(3):1387-1397.

PMID: 37065557 PMC: 10089844. DOI: 10.21037/jtd-23-206.

The different expression of glycogen phosphorylases in renal clear cell renal carcinoma and chromophobe renal carcinoma.

Lu Y, Luo G, Zhu S, Wang X, Chen Y, Dong Z Clin Proteomics. 2020; 17:7.

PMID: 32127786 PMC: 7043045. DOI: 10.1186/s12014-020-9270-0.

Glutathione S-transferase A1 suppresses tumor progression and indicates better prognosis of human primary hepatocellular carcinoma.

Liu X, Sui X, Zhang C, Wei K, Bao Y, Xiong J J Cancer. 2020; 11(1):83-91.

PMID: 31892975 PMC: 6930411. DOI: 10.7150/jca.36495.

References

Valavanidis A, Vlachogianni T, Fiotakis K . Tobacco smoke: involvement of reactive oxygen species and stable free radicals in mechanisms of oxidative damage, carcinogenesis and synergistic effects with other respirable particles. Int J Environ Res Public Health. 2009; 6(2):445-62. PMC: 2672368. DOI: 10.3390/ijerph6020445. View

Ping J, Wang H, Huang M, Liu Z . Genetic analysis of glutathione S-transferase A1 polymorphism in the Chinese population and the influence of genotype on enzymatic properties. Toxicol Sci. 2005; 89(2):438-43. DOI: 10.1093/toxsci/kfj037. View

Coles B, Kadlubar F . Human alpha class glutathione S-transferases: genetic polymorphism, expression, and susceptibility to disease. Methods Enzymol. 2006; 401:9-42. DOI: 10.1016/S0076-6879(05)01002-5. View

Matic M, Pekmezovic T, Djukic T, Mimic-Oka J, Dragicevic D, Krivic B . GSTA1, GSTM1, GSTP1, and GSTT1 polymorphisms and susceptibility to smoking-related bladder cancer: a case-control study. Urol Oncol. 2013; 31(7):1184-92. DOI: 10.1016/j.urolonc.2011.08.005. View

Palma S, Cornetta T, Padua L, Cozzi R, Appolloni M, Ievoli E . Influence of glutathione S-transferase polymorphisms on genotoxic effects induced by tobacco smoke. Mutat Res. 2007; 633(1):1-12. DOI: 10.1016/j.mrgentox.2007.03.014. View

Badjatia N, Satyam A, Singh P, Seth A, Sharma A . Altered antioxidant status and lipid peroxidation in Indian patients with urothelial bladder carcinoma. Urol Oncol. 2009; 28(4):360-7. DOI: 10.1016/j.urolonc.2008.12.010. View

Halliwell B . Oxidative stress and cancer: have we moved forward?. Biochem J. 2006; 401(1):1-11. DOI: 10.1042/BJ20061131. View

Matic M, Simic T, Dragicevic D, Mimic-Oka J, Pljesa-Ercegovac M, Savic-Radojevic A . Isoenzyme profile of glutathione transferases in transitional cell carcinoma of upper urinary tract. Transl Res. 2010; 155(5):256-62. DOI: 10.1016/j.trsl.2009.11.001. View

Soini Y, Haapasaari K, Vaarala M, Turpeenniemi-Hujanen T, Karja V, Karihtala P . 8-hydroxydeguanosine and nitrotyrosine are prognostic factors in urinary bladder carcinoma. Int J Clin Exp Pathol. 2011; 4(3):267-75. PMC: 3071659. View

10.

Reuter S, Gupta S, Chaturvedi M, Aggarwal B . Oxidative stress, inflammation, and cancer: how are they linked?. Free Radic Biol Med. 2010; 49(11):1603-16. PMC: 2990475. DOI: 10.1016/j.freeradbiomed.2010.09.006. View

11.

Garcia-Closas M, Malats N, Silverman D, Dosemeci M, Kogevinas M, Hein D . NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet. 2005; 366(9486):649-59. PMC: 1459966. DOI: 10.1016/S0140-6736(05)67137-1. View

12.

Hayes J, Flanagan J, Jowsey I . Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005; 45:51-88. DOI: 10.1146/annurev.pharmtox.45.120403.095857. View

13.

Yu H, Xia Q, Yan J, Herreno-Saenz D, Wu Y, Tang I . Photoirradiation of polycyclic aromatic hydrocarbons with UVA light - a pathway leading to the generation of reactive oxygen species, lipid peroxidation, and dna damage. Int J Environ Res Public Health. 2006; 3(4):348-54. PMC: 2701161. DOI: 10.3390/ijerph2006030045. View

14.

Mitropoulos D, Deliconstantinos G, Zervas A, Giannopoulos A, Kyriakou G, Dimopoulos C . Oxidative stress of red blood cells during Bacillus Calmette-Guerin intravesical instillations. In Vivo. 2001; 14(6):721-4. View

15.

Pljesa-Ercegovac M, Savic-Radojevic A, Dragicevic D, Mimic-Oka J, Matic M, Sasic T . Enhanced GSTP1 expression in transitional cell carcinoma of urinary bladder is associated with altered apoptotic pathways. Urol Oncol. 2009; 29(1):70-7. DOI: 10.1016/j.urolonc.2008.10.019. View

16.

Malins D, Haimanot R . Major alterations in the nucleotide structure of DNA in cancer of the female breast. Cancer Res. 1991; 51(19):5430-2. View

17.

Shen J, Deininger P, Hunt J, Zhao H . 8-Hydroxy-2'-deoxyguanosine (8-OH-dG) as a potential survival biomarker in patients with nonsmall-cell lung cancer. Cancer. 2006; 109(3):574-80. DOI: 10.1002/cncr.22417. View

18.

Chiou C, Chang P, Chan E, Wu T, Tsao K, Wu J . Urinary 8-hydroxydeoxyguanosine and its analogs as DNA marker of oxidative stress: development of an ELISA and measurement in both bladder and prostate cancers. Clin Chim Acta. 2003; 334(1-2):87-94. DOI: 10.1016/s0009-8981(03)00191-8. View

19.

Simic T, Savic-Radojevic A, Pljesa-Ercegovac M, Matic M, Mimic-Oka J . Glutathione S-transferases in kidney and urinary bladder tumors. Nat Rev Urol. 2009; 6(5):281-9. DOI: 10.1038/nrurol.2009.49. View

20.

Garcia-Closas M, Kelsey K, Hankinson S, Spiegelman D, Springer K, Willett W . Glutathione S-transferase mu and theta polymorphisms and breast cancer susceptibility. J Natl Cancer Inst. 1999; 91(22):1960-4. DOI: 10.1093/jnci/91.22.1960. View